Announcements Trials
Browse Landscape

Phase

Phase 2 78Phase 3 71Phase 1 29Phase 1/2 10Phase NA 5Phase 2/3 5Phase EARLY_PHASE1 2Phase 4 1

Status

Completed 2Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 2INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Colorectal Neoplasms 10Stomach Neoplasms 5Colonic Neoplasms 5Carcinoma, Hepatocellular 4Rectal Neoplasms 3Pancreatic Neoplasms 2Neoplasms 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Biliary Tract Neoplasms 2Vipoma 1Somatostatinoma 1Resected Liver Metastases From Colorectal Cancer 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pathologic Complete Response 1Neutropenia 1Neuroendocrine Tumors 1Malignant Tumor of Pancreas Metastatic to Liver 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia 1Insulinoma 1Glucagonoma 1Gestational Trophoblastic Disease 1Gastrinoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Diarrhea 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Islet Cell 1

Interventions

Oxaliplatin 7Fluorouracil 6Leucovorin 5Bevacizumab 4Watchful Waiting 3Capecitabine 3XELOX 2Neoadjuvant Therapy 2Irinotecan 2Indocyanine Green 2Chemotherapy, Adjuvant 2Cetuximab 2sulindac sulfone 1pembrolizumab 1encorafenib 1dehydroftorafur 1cyclopropapyrroloindole 1Tranexamic Acid 1Standard of Care 1Sentinel Lymph Node Biopsy 1Radiofrequency Ablation 1Preoperative Exercise 1Positron Emission Tomography Computed Tomography 1Panitumumab 1Observation 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Iohexol 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2/3 × Colonic Neoplasms × Leucovorin × Clear all
NCT04068103 2025-05-07

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

NRG Oncology

Phase 2/3 Active not recruiting
635 enrolled 9 charts
Gastrointestinal

Colonic Neoplasms

NCT00952029 2020-03-30

Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer

Federation Francophone de Cancerologie Digestive

Phase 2/3 Completed
492 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00735241 2015-05-22

FAST

Sirtex Medical

Phase 2/3 Withdrawn
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00975897 2013-12-19

Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer

National Cancer Institute (NCI)

Phase 2/3 Completed
3,240 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00274872 2010-02-01

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

National Cancer Institute (NCI)

Phase 2/3 Unknown
600 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡